Non-transferrin-bound iron is associated with biomarkers of oxidative stress, inflammation and endothelial dysfunction in type 2 diabetes

Journal of Diabetes and its Complications

Volumn 29, Issue 7, 2015, Pages 943-949

  Aljwaid, Husam ^a   White, Desley L ^a   Collard, Keith J ^a   Moody, A John ^a   Pinkney, Jonathan H ^b  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

Cardiovascular disease; Endothelial dysfunction; Non transferrin bound iron; Obesity; Oxidative stress; Type 2 diabetes

Indexed keywords

ASCORBIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEMOGLOBIN A1C; INSULIN; IRON; MALONALDEHYDE; METFORMIN; NON TRANSFERRIN BOUND IRON; OXIDIZED ASCORBATE; PIOGLITAZONE; SOLUBLE TRANSFERRIN RECEPTOR; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFLAMMATION; INSULIN TREATMENT; IRON BINDING CAPACITY; IRON BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; AGED; ANALYSIS OF VARIANCE; BLOOD; COMPARATIVE STUDY; COMPLICATION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; VASCULAR ENDOTHELIUM;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOMARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; IRON; MALE; MALONDIALDEHYDE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TRANSFERRINS;

EID: 84939562232     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.05.017     Document Type: Article

References (42)

1. F.I. Adam, P.L. Bounds, R. Kissner, and W.H. Koppenol Redox properties and activity of iron-citrate complexes: Evidence for redox cycling Chemical Research in Toxicology 28 2015 604 614
2. R. Agarwal, and S.D. Chase Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 775 2002 121 126
3. K.J. Ausk, and G.N. Ioannou Is obesity associated with anaemia of chronic disease? A population study Obesity (Silver Spring) 16 2008 2356 2361
4. D. Basuli, R.G. Stevens, F.M. Torti, and S.V. Torti Epidemiological associations between iron and cardiovascular disease and diabetes Frontiers in Pharmacology 2014 5 2014 177 186
5. Y. Beguin Soluble transferrin receptor for the evaluation of erythropoiesis and iron status Clinica Chimica Acta 329 2003 9 22
6. P. Brissot, M. Ropert, C. Le Lan, and O. Loréal Non-transferrin bound iron: A key role in iron overload and iron toxicity Biochimica et Biophysica Acta 1820 2012 403 410
7. A.C. Capeda-Lopez, S.J. Osendarp, A. Melse-Boonstra, I. Aeberli, F. Gonzalez-Salazar, E. Feskins, and et al. Sharply higher rates of iron deficiency in obese Mexican women and children predicted by obesity-related inflammation rather than by differences in dietary iron intake American Journal of Clinical Nutrition 93 2011 975 983
8. K.J. Collard, and D.L. White On the source of the non-transferrin-bound iron which accumulates in packed red blood cell units during storage Blood Transfusion 12 2014 527 532
9. K. Collard, D. White, and A. Copplestone The influence of storage age on iron status, oxidative stress and antioxidant protection in paediatric packed cell units Blood Transfusion 12 2014 210 219
10. E.J. Diamantopoulos, C. Kittas, D. Charitos, E.J. Grigoriadou, G. Ifanti, and S.A. Raptis Impaired erythrocyte deformability precedes vascular changes in experimental diabetes mellitus Hormone and Metabolic Research 36 2004 142 147
11. J.R. Dixon The international conference on harmonisation good clinical practice guideline Quality Assurance 6 1999 65 74
12. T. Ganz, and E. Nemeth Iron sequestration and anaemia of inflammation Seminars in Hematology 46 2009 387 393
13. T. Goto, K. Ikuta, Y. Inamoto, S. Kamoshita, E. Yokohata, D. Koyama, and et al. Hyperferritinemia after adult allogenic hematopoietic cell transplantation: Quantification of iron burden by determining non-transferrin-bound iron International Journal of Hematology 97 2013 125 134
14. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: A 26-year follow up of participants in the Framingham Heart Study Circulation 67 1983 968 977
15. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease. The Framingham study JAMA 241 1979 2035 2038
16. R. Kime, A. Gibson, W. Yong, R. Hider, and H. Powers Chromatographic method for the determination of non-transferrin-bound iron suitable for use on the plasma and bronchoalveolar lavage fluid of preterm babies Clinical Science (London) 91 1996 633 638
17. M.D. Knutson, M. Oukka, L.M. Koss, F. Aydemir, and M. Wessling-Resnick Iron release from macrophages is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin Proceedings of the National Academy of Sciences of the United States of America 102 2005 1324 1328
18. D.H. Lee, and D.R. Jacobs Serum markers of stored body iron are not appropriate markers of health effects of iron: A focus on serum ferritin Medical Hypotheses 62 2004 442 445
19. D.H. Lee, D.Y. Liu, D.R. Jacobs, H.R. Shin, K. Song, I.K. Lee, and et al. Common presence of non-transferrin-bound iron among patients with type 2 diabetes Diabetes Care 29 2006 1090 1095
20. S. Leoncini, V. Rossi, C. Signorini, I. Tanganelli, M. Comporti, and L. Ciccoli Oxidative stress, erythrocyte ageing and plasma non-protein-bound iron in diabetic subjects Free Radical Research 42 2008 716 724
21. D. Maitra, J. Byun, P.R. Andreana, I. Abdulhamid, M.P. Diamond, G.M. Saed, and et al. Reaction of haemoglobin with HOCl: mechanism of heme destruction and free iron release Free Radical Biology and Medicine 51 2011 374 386
22. E. Nemeth, E.V. Valore, M. Territo, G. Schiller, A. Lichtenstein, and T. Ganz Hepcidin, a putative mediator of anaemia of inflammation, is a type II acute-phase protein Blood 101 2003 2461 2463
23. J.B. Porter, P.B. Walter, L.D. Neumayer, P. Evans, S. Bansal, M. Garbowski, and et al. Mechanisms of plasma non-transferrin-bound iron generation: Insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients British Journal of Haematology 167 2014 692 696
24. H. Resmi, H. Akhunlar, A. Temez Artmann, and G. Guner In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes Cell Biochemistry and Function 23 2005 163 168
25. B. Riquelme, P. Foresto, M. D'Arrigo, J. Valverde, and R. Rasia A dynamic and stationary rheological study of erythrocytes incubated in a glucose medium Journal of Biochemical and Biophysical Methods 62 2005 131 141
26. T.M. Rooyakkers, E.S.G. Stroes, M.P. Kooistra, E.E. van Faassen, R.C. Hider, T.J. Rabelink, and et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo European Journal of Clinical Investigation 32 2002 9 16
27. K. Sasaki, K. Ikuta, H. Tanaka, T. Ohtake, Y. Torimoto, M. Fujiya, and et al. Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination Molecular Medicine Reports 4 2011 913 918
28. Y. Sato, T. Uchiki, M. Iwama, Y. Kishimoto, R. Takahashi, and A. Ishigami Determination of dehydroascorbic acid in mouse tissues and plasma by using tris(2-carboxyethyl) phosphine hydrochloride as reductant in metasphosphoric acid/ethelenediaminetetraacetic acid solution Biological and Pharmaceutical Bulletin 33 2010 364 369
29. J.A. Simcox, and D.A. McClain Iron and diabetes risk Cell Metabolism 17 2013 329 341
30. M.N. Starodubtseva, T.G. Kuznetsova, N.I. Yegorenkov, and S.N. Cherenkevich Structural and mechanical characteristics of erythrocyte membranes in patients with type 2 diabetes mellitus Bulletin of Experimental Biology and Medicine 145 2008 99 103
31. M. Sulieman, R. Asleh, Z.I. Cabantchik, W. Breuer, D. Aronson, A. Suleiman, and et al. Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes Diabetes Care 27 2004 2730 2732
32. A. Taher, K.M. Musallam, F. El Rassi, L. Duca, A. Inati, S. Koussa, and et al. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassemia intermedia British Journal of Haematology 146 2009 569 572
33. L.I. Tanner, and G.E. Lienhard Insulin elicits a redistribution of transferrin receptors in 3 T3-L1 adipocytes through an increase in the rate constant for receptor externalisation Journal of Biological Chemistry 262 1987 8975 8980
34. A. Van Campenhaut, C. Van Campenhaut, A.R. Lagrou, G. Moorkens, C. De Block, and B. Manuel-y-Keenoy Iron-binding antioxidant capacity is impaired in diabetes mellitus Free Radical Biology and Medicine 40 2006 1749 1755
35. F. Vinchi, M.U. Muckenthaler, M.C. Da Silva, G. Balla, J. Balla, and V. Veney Atherogenesis and iron: From epidemiology to cellular level Frontiers in Pharmacology 5 2014 94 113
36. F. Vinchi, and E. Tolosano Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: Scavenging free heme to preserve vascular homeostasis Oxidative Medicine and Cellular Longevity 396527 2013 1 11
37. S. Waldvogel-Abramowski, G. Waeber, C. Gassner, A. Buser, B.M. Frey, B. Favrat, and et al. Physiology of iron metabolism Transfusion Medicine and Hemotherapy 41 2014 213 321
38. D.L. White, and A. Collinson Red meat, dietary heme iron, and risk of type 2 diabetes: The involvement of advanced lipoxidation endproducts Advances in Nutrition 4 2013 404 411
39. L.B. Yanoff, C.M. Menzie, B. Denlinger, N.G. Sebring, T. McHugh, A.T. Remalay, and et al. Inflammation and iron deficiency in the hypoferremia of obesity International Journal of Obesity 31 2007 1412 1419
40. C. Zafon, A. Lecube, and R. Simó Iron in obesity. An ancient micronutrient for a modern disease Obesity Reviews 11 2010 322 328
41. W.J. Zhang, and B. Frei Intracellular metal ion chelators inhibit TNF-α-induced PP-I activation and adhesion molecule expression in human aortic endothelial cells Free Radical Biology and Medicine 34 2003 674 682
42. Q. Zhang, M.E. Monroe, A.A. Schepmoes, T.R.W. Clauss, M.A. Gritsenko, D. Meng, and et al. Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects Journal of Proteome Research 10 2011 3076 3088